血管内皮生长因子家族在冠心病发生发展中的作用及研究现状
The Role of Vascular Endothelial Growth Factor Family in the Development of Coronary Heart Disease
DOI: 10.12677/ACM.2022.1281102, PDF,   
作者: 薛晋荣, 张梦奇, 巩杨超:西安医学院,陕西 西安;祝 领, 姜 馨*:陕西省人民医院心血管内科,陕西 西安
关键词: 血管内皮生长因子冠心病细胞因子Vascular Endothelial Growth Factor Coronary Heart Disease Cytokines
摘要: 血管内皮生长因子(Vascular endothelial growth factor, VEGF)是一类发现较早且作用广泛的细胞因子,作为一种促血管内皮细胞生长的细胞因子,VEGF (Vascular endothelial growth factor, VEGF)可增加血管通透性,促进血管内皮细胞增生及血管形成,是血管和淋巴管的调节因子。过去有关VEGF (Vascular endothelial growth factor, VEGF)的研究主要集中在肿瘤和眼科领域。近年来,随着心血管领域研究的进一步深入,越来越多的研究发现,它参与了动脉粥样硬化和其他心血管疾病的发展,尤其是在冠状动脉粥样硬化性心脏病的发生发展过程中发挥着重要的作用。目前的研究发现,在人类中,VEGF家族(Vascular endothelial growth factor, VEGF)由5个独立的基因产物组成:调节血管生长的VEGF-A (Vascular endothelial growth factor A, VEGF-A)、VEGF-B (Vascular endothelial growth factor B, VEGF-B)、胎盘生长因子(placental growth factor, PlGF)以及调节淋巴管生成的VEGF-C (Vascular endothelial growth factor C, VEGF-C)和VEGF-D (Vascular endothelial growth factor D, VEGF-D)。它们在冠心病发生发展过程中展现出各自的抗炎及促炎作用。本文将对血管内皮生长因子家族在冠心病发生发展中的作用及研究现状进行综述,为以后的基础研究或者临床实践提供一些参考。
Abstract: Vascular endothelial growth factor (VEGF) is a kind of cytokines discovered earlier and widely used. As a cytokine that promotes the growth of vascular endothelial cells, VEGF can increase vascular permeability, promote vascular endothelial cell proliferation and angiogenesis, and is a regulator of blood vessels and lymphatic vessels. In the past, studies on VEGF mainly focused on the fields of tu-mor and ophthalmology. In recent years, with the further research in the field of cardiovascular, more and more studies have found that it is involved in the development of atherosclerosis and other cardiovascular diseases, especially in the occurrence and development of coronary athero-sclerotic heart disease plays an important role. Current studies have found that in humans, the VEGF family consists of five independent genetic products: VEGF-A, VEGF-B, placental growth factor regulating vascular growth, and VEGF-C and VEGF-D regulating lymphangiogenesis. They show their anti-inflammatory and pro-inflammatory effects in the development of coronary heart disease. This article will review the role and research status of vascular endothelial growth factor family in the development of coronary heart disease, and provide some reference for future basic research or clinical practice.
文章引用:薛晋荣, 张梦奇, 巩杨超, 祝领, 姜馨. 血管内皮生长因子家族在冠心病发生发展中的作用及研究现状[J]. 临床医学进展, 2022, 12(8): 7634-7640. https://doi.org/10.12677/ACM.2022.1281102

参考文献

[1] Zhu, K.F., Wang, Y.M., Zhu, J.Z., et al. (2016) National Prevalence of Coronary Heart Disease and Its Relationship with Human Development Index: A Systematic Review. European Journal of Preventive Cardiology, 23, 530-543. [Google Scholar] [CrossRef] [PubMed]
[2] Hansson, G.K. (2005) Inflammation, Atherosclerosis, and Coro-nary Artery Disease. New England Journal of Medicine, 352, 1685-1695. [Google Scholar] [CrossRef
[3] Carlevaro, M.F., Cermelli, S., Cancedda, R., et al. (2000) Vascular Endothelial Growth Factor (VEGF) in Cartilage Neovascularization and Chondrocyte Differentiation: Auto-Paracrine Role during Endochondral Bone Formation. Journal of Cell Science, 113, 59-69. [Google Scholar] [CrossRef] [PubMed]
[4] Melincovici, C.S., Boşca, A.B., Şuşman, S., et al. (2018) Vascular Endo-thelial Growth Factor (VEGF)—Key Factor in Normal and Pathological Angiogenesis. Romanian Journal of Morpholo-gy and Embryology, 59, 455-467.
[5] Claesson-Welsh, L. and Welsh, M. (2013) VEGFA and Tumour Angiogenesis. Journal of Internal Medicine, 273, 114-127. [Google Scholar] [CrossRef] [PubMed]
[6] Itatani, Y., Kawada, K., Yamamoto, T., et al. (2018) Resistance to Anti-Angiogenic Therapy in Cancer-Alterations to Anti-VEGF Pathway. In-ternational Journal of Molecular Sciences, 19, Article No. 1232. [Google Scholar] [CrossRef] [PubMed]
[7] Garcia, R., Bouleti, C., Sirol, M., et al. (2019) VEGF-A Plasma Levels Are Associated with Microvascular Obstruction in Patients with ST-Segment Elevation Myocardial Infarction. Interna-tional Journal of Cardiology, 291, 19-24. [Google Scholar] [CrossRef] [PubMed]
[8] Zhao, Y., Kong, L., Pei, Z., et al. (2021) m7G Methyltransferase METTL1 Promotes Post-Ischemic Angiogenesis via Promoting VEGFA mRNA Translation. Frontiers in Cell and De-velopmental Biology, 9, Article ID: 642080. [Google Scholar] [CrossRef] [PubMed]
[9] Tang, H., Zhang, S., Huang, C., et al. (2021) MiR-448-5p/VEGFA Axis Protects Cardiomyocytes from Hypoxia Through Regulating the FAS/FAS-L Signaling Pathway. International Heart Journal, 62, 647-657. [Google Scholar] [CrossRef] [PubMed]
[10] Zou, J., Fei, Q., Xiao, H., et al. (2019) VEGF-A Promotes Angiogenesis after Acute Myocardial Infarction through Increasing ROS Production and Enhancing ER Stress-Mediated Autophagy. Journal of Cellular Physiology, 234, 17690- 17703. [Google Scholar] [CrossRef] [PubMed]
[11] Liu, T., Sun, F., Cui, J., et al. (2020) Morroniside Enhances Angiogenesis and Improves Cardiac Function Following Acute Myocardial Infarc-tion in Rats. European Journal of Pharmacology, 872, Article ID: 172954. [Google Scholar] [CrossRef] [PubMed]
[12] Zou, J., Wang, N., Liu, M., et al. (2018) Nucleolin Mediated Pro-Angiogenic Role of Hydroxysafflor Yellow A in Ischaemic Cardiac Dysfunction: Post-Transcriptional Regulation of VEGF-A and MMP-9. Journal of Cellular and Molecular Medicine, 22, 2692-2705. [Google Scholar] [CrossRef] [PubMed]
[13] Wang, H., Chen, L., Wang, S., et al. (2021) Tetrandrine Promotes Angi-ogenesis via Transcriptional Regulation of VEGF-A. Vascular Pharmacology, 141, Article ID: 106920. [Google Scholar] [CrossRef] [PubMed]
[14] Lv, Y.X., Zhong, S., Tang, H., et al. (2018) VEGF-A and VEGF-B Coordinate the Arteriogenesis to Repair the Infarcted Heart with Vagus Nerve Stimulation. Cellular Physiology and Biochemistry, 48, 433-449. [Google Scholar] [CrossRef] [PubMed]
[15] Kivelä, R., Bry, M., Robciuc, M.R., et al. (2014) VEGF-B-Induced Vas-cular Growth Leads to Metabolic Reprogramming and Ischemia Resistance in the Heart. EMBO Molecular Medicine, 6, 307-321. [Google Scholar] [CrossRef] [PubMed]
[16] Bulysheva, A.A., Burcus, N., Lundberg, C.G., et al. (2018) VEGF-B Electrotransfer Mediated Gene Therapy Induces Cardiomyogenesis in a Rat Model of Cardiac Ischemia. Bioe-lectrochemistry, 124, 105-111. [Google Scholar] [CrossRef] [PubMed]
[17] Korpela, H., Hätinen, O.P., Nieminen, T., et al. (2021) Ad-enoviral VEGF-B186R127S Gene Transfer Induces Angiogenesis and Improves Perfusion in Ischemic Heart. iScience, 24, Article ID: 103533. [Google Scholar] [CrossRef] [PubMed]
[18] Lähteenvuo, J.E., Lähteenvuo, M.T., Kivelä, A., et al. (2009) Vas-cular Endothelial Growth Factor-B Induces Myocardium-Specific Angiogenesis and Arteriogenesis via Vascular Endo-thelial Growth Factor Receptor-1- and Neuropilin Receptor-1-Dependent Mechanisms. Circulation, 119, 845-856. [Google Scholar] [CrossRef
[19] Nurro, J., Halonen, P.J., Kuivanen, A., et al. (2016) AdVEGF-B186 and AdVEGF-DΔNΔC Induce Angiogenesis and Increase Perfusion in Porcine Myocardium. Heart, 102, 1716-1720. [Google Scholar] [CrossRef] [PubMed]
[20] Suh, S.H., Choe, K., Hong, S.P., et al. (2019) Gut Microbiota Regulates Lacteal Integrity by Inducing VEGF-C in Intestinal Villus Macrophages. EMBO Re-ports, 20, e46927. [Google Scholar] [CrossRef] [PubMed]
[21] Wada, H., Suzuki, M., Matsuda, M., et al. (2018) VEGF-C and Mortality in Patients with Suspected or Known Coronary Artery Disease. Journal of the American Heart Association, 7, e010355. [Google Scholar] [CrossRef
[22] Chen, X.G., Lv, Y.X., Zhao, D., et al. (2016) Vascular Endothelial Growth Factor-C Protects Heart from Ischemia/ Reperfusion Injury by Inhibiting Cardiomyocyte Apoptosis. Molecular and Cellular Biochemistry, 413, 9-23. [Google Scholar] [CrossRef] [PubMed]
[23] Zhang, H.F., Wang, Y.L., Tan, Y.Z., et al. (2019) Enhancement of Cardiac Lymphangiogenesis by Transplantation of CD34(+)VEGFR-3(+) Endothelial Progenitor Cells and Sustained Release of VEGF-C. Basic Research in Cardiology, 114, Article No. 43. [Google Scholar] [CrossRef] [PubMed]
[24] Yue, Y., Huang, S., Wang, L., et al. (2020) M2b Macrophages Regulate Cardiac Fibroblast Activation and Alleviate Cardiac Fibrosis after Reperfusion Injury. Circulation Journal, 84, 626-635. [Google Scholar] [CrossRef
[25] Fox, K.A.A., Metra, M., Morais, J., et al. (2020) The Myth of “Stable” Coronary Artery Disease. Nature Reviews Cardiology, 17, 9-21. [Google Scholar] [CrossRef] [PubMed]
[26] Zhao, W., Zhao, T., Chen, Y., et al. (2015) Angiotensin 1-7 Pro-motes Cardiac Angiogenesis Following Infarction. Current Vascular Pharmacology, 13, 37-42. [Google Scholar] [CrossRef] [PubMed]
[27] (2018) Corrigendum to: Adenoviral Intramyocardial VEGF-DΔNΔC Gene Transfer Increases Myocardial Perfusion Reserve in Refractory Angina Patients: A Phase I/IIa Study with 1-Year Follow-Up. European Heart Journal, 39, Article No. 1652. [Google Scholar] [CrossRef] [PubMed]
[28] Saito, Y. (2021) The Role of the PlGF/Flt-1 Signaling Pathway in the Cardiorenal Connection. The Journal of Molecular and Cellular Cardiology, 151, 106-112. [Google Scholar] [CrossRef] [PubMed]
[29] Dewerchin, M. and Carmeliet, P. (2012) PlGF: A Multitasking Cytokine with Disease-Restricted Activity. Cold Spring Harbor Perspectives in Medicine, 2, a011056. [Google Scholar] [CrossRef] [PubMed]
[30] Zhang, Y., Cao, C., Xin, J., et al. (2018) Treatment with Placental Growth Factor Attenuates Myocardial Ischemia/Reperfusion Injury. PLOS ONE, 13, e0202772. [Google Scholar] [CrossRef] [PubMed]
[31] Takeda, Y., Uemura, S., Iwama, H., et al. (2009) Treatment with Recombinant Placental Growth Factor (PlGF) Enhances both Angiogenesis and Arteriogenesis and Improves Survival after Myocardial Infarction. Circulation Journal, 73, 1674-1682. [Google Scholar] [CrossRef
[32] Luttun, A., Tjwa, M., Moons, L., et al. (2002) Revascularization of Ischemic Tissues by PlGF Treatment, and Inhibition of Tumor Angiogenesis, Arthritis and Atherosclerosis by Anti-Flt1. Nature Medicine, 8, 831-840. [Google Scholar] [CrossRef] [PubMed]
[33] Li, B., Sharpe, E.E., Maupin, A.B., et al. (2006) VEGF and PlGF Promote Adult Vasculogenesis by Enhancing EPC Recruitment and Vessel Formation at the Site of Tumor Neovascularization. The FASEB Journal, 20, 1495-1497. [Google Scholar] [CrossRef] [PubMed]
[34] Iwama, H., Uemura, S., Naya, N., et al. (2006) Cardiac Expression of Placental Growth Factor Predicts the Improvement of Chronic Phase Left Ventricular Function in Patients with Acute Myocardial Infarction. Journal of the American College of Cardiology, 47, 1559-1567. [Google Scholar] [CrossRef] [PubMed]
[35] Matsumoto, T., Uemura, S., Takeda, Y., et al. (2013) An Elevated Ratio of Placental Growth Factor to Soluble FMS-Like Tyrosine Kinase-1 Predicts Adverse Outcomes in Patients with Stable Coronary Artery Disease. Internal Medicine, 52, 1019-1027. [Google Scholar] [CrossRef] [PubMed]
[36] Iwasaki, H., Kawamoto, A., Tjwa, M., et al. (2011) PlGF Repairs Myocardial Ischemia through Mechanisms of Angiogenesis, Cardioprotection and Recruitment of Myo-Angiogenic Competent Marrow Progenitors. PLOS ONE, 6, e24872. [Google Scholar] [CrossRef] [PubMed]